Fady Ibraham Malik Cytokinetics Inc (CYTK) insider trading activity

Fady Ibraham Malik is EVP Research & Development of CYTOKINETICS INC. Currently has a direct ownership of 131,004 shares of CYTK, which is worth approximately $7.2 Million. The most recent transaction as insider was on Feb 26, 2021, when has been sold 7,060 shares (Common Stock) at a price of $18.73 per share, resulting in proceeds of $132,234. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 131K

5.46% 3M change

19.71% 12M change

Total Value Held $7.2 Million

Fady Ibraham Malik Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 26 2021	SELL Payment of exercise price or tax liability	$132,234 $18.73 p/Share	7,060 Reduced 4.74%	141,749 Common Stock
Feb 11 2021	SELL Open market or private sale	$38,091 $23.34 p/Share	1,632 Reduced 1.08%	148,809 Common Stock
Jan 14 2021	SELL Open market or private sale	$240,625 $19.25 p/Share	12,500 Reduced 7.67%	150,441 Common Stock
Jan 14 2021	BUY Exercise of conversion of derivative security	$117,750 $9.42 p/Share	12,500 Added 7.15%	162,324 Common Stock
Dec 10 2020	SELL Open market or private sale	$21,177 $20.13 p/Share	1,052 Reduced 0.69%	150,441 Common Stock
Nov 12 2020	SELL Open market or private sale	$21,112 $17.15 p/Share	1,231 Reduced 0.81%	150,951 Common Stock
Oct 08 2020	SELL Open market or private sale	$21,952 $17.45 p/Share	1,258 Reduced 0.82%	152,182 Common Stock

Also insider at

RCKT

ROCKET PHARMACEUTICALS, INC. Healthcare

FIM